Profile data is unavailable for this security.
About the company
Kyorin Pharmaceutical Co Ltd, formerly Kyorin Holdings Inc, is a Japan-based company mainly engaged in the pharmaceuticals business. The Pharmaceuticals segment is mainly engaged in the manufacture, purchase, sales and testing of pharmaceutical products, the purchase of raw materials for pharmaceuticals, the evaluation of technologies, the inspection, analysis and negotiation of license affiliations, the operations related to clinical trials and information gathering such as searching for drug discovery seeds, as well as the drug candidate compound discovery research and compound evaluation business. The Company also conducts the diagnostic businesses and verifies and creates research targets that are directly linked to drug discovery.
- Revenue in JPY (TTM)119.53bn
- Net income in JPY5.32bn
- Incorporated1958
- Employees2.14k
- LocationKyorin Pharmaceutical Co Ltd15/16F, Ochanomizu Sorashiti4-6, Kanda SurugadaiCHIYODA-KU 101-8311JapanJPN
- Phone+81 335254700
- Fax+81 335254780
- Websitehttps://www.kyorin-pharm.co.jp/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ispace Inc | 2.36bn | -2.37bn | 67.99bn | 216.00 | -- | 6.98 | -- | 28.84 | -31.36 | -31.36 | 29.06 | 104.64 | 0.1377 | 7.48 | 98.55 | -- | -13.83 | -- | -24.15 | -- | 39.38 | -- | -100.39 | -- | 2.05 | -- | 0.5623 | -- | 138.27 | -- | 79.24 | -- | -- | -- |
Cuorips Inc | 23.10m | -632.18m | 68.13bn | 46.00 | -- | 11.37 | -- | 2,948.98 | -86.04 | -86.04 | 3.14 | 752.26 | 0.0047 | 4.66 | 17.57 | -- | -12.94 | -- | -13.30 | -- | 41.69 | -- | -2,736.49 | -- | 33.80 | -- | -- | -- | -39.65 | -- | -39.84 | -- | -- | -- |
ASKA Pharmaceutical Holdings Co Ltd | 62.84bn | 7.55bn | 73.32bn | 747.00 | 9.00 | 1.10 | 8.58 | 1.17 | 266.48 | 266.48 | 2,219.59 | 2,186.08 | 0.7066 | 1.69 | 4.08 | -- | 8.48 | 4.63 | 11.08 | 5.87 | 48.80 | 46.94 | 12.01 | 6.76 | 1.49 | -- | 0.1328 | 14.42 | 3.94 | 6.12 | 78.03 | 34.04 | -37.89 | 23.36 |
Katakura Industries Co., Ltd. | 39.83bn | 3.01bn | 73.95bn | 1.04k | 23.10 | 0.9023 | 12.56 | 1.86 | 90.90 | 90.90 | 1,203.27 | 2,327.46 | 0.2858 | 2.35 | 4.49 | 38,300,000.00 | 2.29 | 2.35 | 2.99 | 3.34 | 38.30 | 37.75 | 8.01 | 8.32 | 2.58 | -- | 0.1097 | 18.81 | 16.62 | -2.04 | 8.09 | 18.87 | -7.46 | 10.76 |
JCR Pharmaceuticals Co Ltd | 42.87bn | 5.51bn | 76.13bn | 879.00 | 13.37 | 1.30 | 10.23 | 1.78 | 43.91 | 43.91 | 342.28 | 450.13 | 0.4349 | 0.5891 | 3.29 | -- | 5.62 | 8.66 | 8.47 | 13.46 | 72.90 | 74.51 | 12.92 | 18.24 | 1.22 | 27.69 | 0.2921 | 29.60 | 24.83 | 13.11 | 46.00 | 8.19 | 18.54 | 21.67 |
Eiken Chemical Co Ltd | 40.05bn | 2.63bn | 79.67bn | 754.00 | 29.31 | 1.56 | 18.64 | 1.99 | 70.52 | 70.52 | 1,080.89 | 1,328.72 | 0.6262 | 2.83 | 3.40 | -- | 4.12 | 8.01 | 5.06 | 10.14 | 41.76 | 45.92 | 6.58 | 11.50 | 2.62 | -- | 0.0862 | 35.21 | -7.44 | 2.29 | -54.08 | -5.24 | 11.66 | 11.20 |
Torii Pharmaceutical Co Ltd | 56.28bn | 5.29bn | 104.26bn | 583.00 | 19.25 | 0.8547 | 18.15 | 1.85 | 188.05 | 188.05 | 2,002.44 | 4,235.56 | 0.4288 | 2.72 | 2.25 | 96,531,740.00 | 4.03 | 6.52 | 4.44 | 7.35 | 44.83 | 49.55 | 9.40 | 17.98 | 5.58 | -- | 0.00 | 24.17 | 11.74 | -2.67 | 4.44 | 28.76 | -20.38 | 20.11 |
Kyorin Pharmaceutical Co Ltd | 119.53bn | 5.32bn | 108.74bn | 2.14k | 18.16 | 0.7393 | 12.72 | 0.9097 | 92.70 | 92.70 | 2,082.82 | 2,276.51 | 0.6759 | 1.34 | 2.61 | -- | 3.01 | 3.05 | 3.90 | 3.79 | 43.01 | 47.11 | 4.45 | 4.76 | 1.45 | -- | 0.138 | 66.81 | 5.53 | 1.02 | 12.68 | -4.98 | 7.41 | -7.06 |
Mochida Pharmaceutical Co Ltd | 102.89bn | 4.55bn | 109.49bn | 1.53k | 23.13 | 0.8095 | 16.84 | 1.06 | 126.33 | 126.33 | 2,868.81 | 3,609.64 | 0.6478 | 1.86 | 3.28 | -- | 2.86 | 4.37 | 3.44 | 5.31 | 50.61 | 52.47 | 4.42 | 6.71 | 3.31 | -- | -- | 44.88 | -0.3641 | -1.26 | -31.61 | -11.63 | 10.91 | -1.21 |
Zeria Pharmaceutical Co Ltd | 75.73bn | 7.73bn | 110.38bn | 1.73k | 11.85 | 1.15 | 8.24 | 1.46 | 175.39 | 175.39 | 1,717.90 | 1,806.33 | 0.5304 | 1.48 | 3.99 | -- | 5.39 | 3.89 | 8.39 | 6.28 | 73.29 | 71.93 | 10.16 | 7.57 | 0.7946 | 13.04 | 0.3667 | 35.00 | 10.74 | 4.14 | 24.78 | 17.49 | 20.77 | 5.29 |
GNI Group Ltd | 27.75bn | 9.55bn | 114.46bn | 843.00 | 12.17 | 3.30 | 9.65 | 4.12 | 188.10 | 188.10 | 554.62 | 693.41 | 0.5569 | 2.01 | 7.89 | 32,921,710.00 | 22.45 | 7.23 | 26.73 | 8.80 | 84.78 | 85.75 | 40.32 | 14.57 | 2.74 | 30.59 | 0.1417 | 0.00 | 49.32 | 38.97 | 1,981.71 | -- | 19.69 | -- |
Takara Bio Inc | 43.51bn | 1.48bn | 121.38bn | 1.79k | 82.01 | 1.09 | 18.88 | 2.79 | 12.29 | 12.29 | 361.29 | 926.00 | 0.3474 | 1.45 | 3.71 | -- | 1.21 | 10.06 | 1.32 | 11.38 | 61.85 | 64.39 | 3.47 | 18.84 | 7.10 | -- | 0.0086 | 27.55 | -44.33 | 3.95 | -90.76 | -16.55 | 16.18 | 19.42 |
Sumitomo Pharma Co Ltd | 314.56bn | -314.97bn | 136.08bn | 6.25k | -- | 0.8706 | -- | 0.4326 | -792.79 | -792.79 | 791.76 | 392.82 | 0.308 | 1.21 | 3.76 | -- | -30.84 | -5.07 | -54.58 | -7.73 | 59.76 | 69.99 | -100.12 | -12.28 | 0.2992 | -- | 0.7285 | -- | -43.38 | -7.29 | -322.71 | -- | 4.02 | -- |
Nxera Pharma Co Ltd | 16.43bn | -9.07bn | 137.82bn | 350.00 | -- | 2.08 | -- | 8.39 | -107.30 | -107.30 | 194.96 | 736.60 | 0.1309 | -- | 5.77 | 46,954,280.00 | -7.23 | -0.6588 | -7.78 | -0.7036 | 74.44 | 89.83 | -55.20 | -4.46 | 4.03 | -10.91 | 0.5238 | -- | -18.00 | -- | -1,982.98 | -- | -- | -- |
Towa Pharmaceutical Co Ltd | 227.93bn | 16.17bn | 155.06bn | 4.30k | 9.16 | 0.9504 | 6.27 | 0.6803 | 328.58 | 328.58 | 4,630.88 | 3,167.26 | 0.5684 | 1.51 | 3.66 | -- | 4.03 | 4.21 | 5.03 | 5.63 | 35.70 | 39.23 | 7.10 | 7.23 | 1.46 | -- | 0.5649 | 20.79 | 9.13 | 16.74 | 634.80 | 3.72 | 28.20 | 10.86 |
Kissei Pharmaceutical Co Ltd | 75.58bn | 11.16bn | 155.08bn | 1.80k | 12.76 | 0.6319 | 9.98 | 2.05 | 246.57 | 246.57 | 1,669.95 | 4,977.43 | 0.3135 | 1.56 | 2.94 | -- | 4.68 | 3.61 | 5.05 | 3.90 | 49.41 | 49.47 | 14.94 | 12.69 | 4.43 | -- | 0.006 | 34.69 | 11.98 | 0.8919 | 6.00 | 15.28 | 6.58 | 10.40 |
Holder | Shares | % Held |
---|---|---|
Kopernik Global Investors LLCas of 15 Jun 2023 | 4.03m | 6.23% |
The Vanguard Group, Inc.as of 06 Jun 2024 | 1.70m | 2.62% |
Amundi Japan Ltd.as of 12 Jun 2024 | 1.45m | 2.25% |
Nomura Asset Management Co., Ltd.as of 31 May 2024 | 1.35m | 2.08% |
BlackRock Fund Advisorsas of 06 Jun 2024 | 781.30k | 1.21% |
Dimensional Fund Advisors LPas of 06 Jun 2024 | 643.45k | 1.00% |
Nikko Asset Management Co., Ltd.as of 07 Jun 2024 | 634.40k | 0.98% |
Daiwa Asset Management Co. Ltd.as of 30 Apr 2024 | 604.70k | 0.94% |
Janus Henderson Investors (Singapore) Ltd.as of 31 Mar 2024 | 474.20k | 0.73% |
Sompo Asset Management Co. Ltd.as of 10 Oct 2023 | 344.40k | 0.53% |